Tilray (NASDAQ:TLRY) Shares Gap Down to $2.15

Tilray Inc (NASDAQ:TLRY)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $2.15, but opened at $2.09. Tilray shares last traded at $2.24, with a volume of 8,657,552 shares.

Tilray Stock Up 7.4 %

The stock’s 50 day moving average price is $1.87 and its two-hundred day moving average price is $2.00. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.63 and a quick ratio of 0.99.

Insider Activity at Tilray

In related news, CEO Irwin D. Simon bought 53,700 shares of the business’s stock in a transaction that occurred on Friday, January 12th. The stock was purchased at an average cost of $1.88 per share, for a total transaction of $100,956.00. Following the purchase, the chief executive officer now directly owns 2,033,058 shares in the company, valued at $3,822,149.04. The purchase was disclosed in a filing with the SEC, which is available through this link. In related news, CEO Irwin D. Simon bought 53,700 shares of the business’s stock in a transaction that occurred on Friday, January 12th. The stock was purchased at an average cost of $1.88 per share, for a total transaction of $100,956.00. Following the purchase, the chief executive officer now directly owns 2,033,058 shares in the company, valued at $3,822,149.04. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, CFO Carl A. Merton bought 20,000 shares of the business’s stock in a transaction that occurred on Friday, January 12th. The shares were bought at an average price of $1.87 per share, with a total value of $37,400.00. Following the completion of the purchase, the chief financial officer now owns 20,000 shares in the company, valued at $37,400. The disclosure for this purchase can be found here. Insiders purchased a total of 96,300 shares of company stock worth $183,210 in the last ninety days. 0.68% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Tilray

Several large investors have recently made changes to their positions in TLRY. Clear Street Markets LLC bought a new stake in shares of Tilray in the 3rd quarter worth about $25,000. Macquarie Group Ltd. grew its holdings in Tilray by 188.8% during the 2nd quarter. Macquarie Group Ltd. now owns 8,540 shares of the company’s stock worth $27,000 after acquiring an additional 5,583 shares during the last quarter. Oppenheimer & Co. Inc. bought a new stake in Tilray during the 4th quarter worth about $27,000. Lake Street Financial LLC bought a new stake in Tilray during the 3rd quarter worth about $28,000. Finally, Gainplan LLC bought a new stake in Tilray during the 4th quarter worth about $28,000. Institutional investors own 9.35% of the company’s stock.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.